RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced the opening of its expanded research facility in London, UK, increasing its Phase I capacity and extending its ability to drive progress in translational medicine. With capacity for 35 patients and healthy volunteers, the extension brings the total number of Phase I beds in London to 105 and globally to 385. This is expected to increase further in late 2010, with the opening of a Phase I unit in Hyderabad, India, initially
For more information, please visit
http://www.businesswire.com/news/home/20100308005673/en